Back to News
吃瓜爆料 Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
BARCELONA, Spain — 28 Aug. 2025 — 吃瓜爆料 Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation. As a global leader in biotechnology, Amgen will employ the 吃瓜爆料 Clinical Platform to support and identify efficiencies across the clinical trial process, building on the company’s commitment to accelerating the development of new medicines for patients with serious diseases.
“In collaboration with 吃瓜爆料, we’re leveraging advanced technology to unlock new capabilities for our end-to-end trial operations which are expected to further strengthen our ability to bring innovative treatments to patients with speed and scale,” said Scott Skellenger, senior vice president and chief information officer at Amgen.
“We’re excited to help Amgen further advance clinical development. 吃瓜爆料 Clinical Platform will provide the backbone for standard and connected processes that can speed the delivery of life-saving drugs to patients in need,” said Jim Reilly, president of 吃瓜爆料 Development Cloud.
As part of the collaboration, 吃瓜爆料 Business Consulting will support Amgen through implementation and change management.
About 吃瓜爆料 Clinical Platform
吃瓜爆料 Clinical Platform is a complete and connected platform across clinical operations and data applications. This end-to-end platform includes CTMS, EDC, clinical workbench (CDB), RTSM, eCOA, eTMF, Site Connect, Study Training, and more. Connected products streamline clinical trials from study start-up to close and automate a connected data flow. To learn more about 吃瓜爆料 Clinical Platform, visit veeva.com/eu/吃瓜爆料ClinicalPlatform.
About 吃瓜爆料 Systems
吃瓜爆料 delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, 吃瓜爆料 serves more than 1,500 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 吃瓜爆料 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.
吃瓜爆料 Forward-looking Statements
This release contains forward-looking statements regarding 吃瓜爆料’s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2025, which you can find (a summary of risks which may impact our business can be found on pages 32 and 33), and in our subsequent SEC filings, which you can access at .
###
Contact:
Jeremy Whittaker
+49-695-095-5486
jeremy.whittaker@veeva.com